sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Viral clearance Market by Method (Viral Removal, Viral Inactivation), by Application (Recombinant Proteins, Blood and Blood Products, Cellular and Gene Therapy Products, Vaccine, Other Applications), by End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2022-2030

Viral clearance Market by Method (Viral Removal, Viral Inactivation), by...

Home / Categories / Healthcare
Viral clearance Market by Method (Viral Removal, Viral Inactivation), by Application (Recombinant Proteins, Blood and Blood Products, Cellular and Gene Therapy Products, Vaccine, Other Applications), by End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2022-2030
Viral clearance Market by Method...
Report Code
RO14/128/2888

Publish Date
01/Feb/2023

Pages
200
PRICE
$ 4900/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5400/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 8700/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
The global viral clearance market size was US$ 425.9 million in 2021. The global viral clearance market size is estimated to reach US$ 894.9 million by 2030, growing at a compound annual growth rate (CAGR) of 8.6% during the forecast period from 2022 to 2030.
Viral clearance is an important process in the growth of recombinant proteins, monoclonal antibodies, glycoproteins, medical devices, and tissue and blood-derived products. This is because these products are prone to decay by chemical impurities, bacteria and fungi, and viruses. It is a vital process during the downstream purification of biologics, therapeutic blood, and tissue-derived materials. They are either inactivated or terminated by the virus to form microbially durable objects.

Factors Affecting Marketing Growth

An increase in need in pharmaceutical and biotechnological industries is the key element driving the growth of the global market.
The rise in the number of new drug releases in various components and related drug approval techniques drives the growth of the global market.
A high degree of consolidation act hinders the growth of the global market.

Impact on COVID-19 Analysis
COVID-19 had a positive impact on the growth of the global market. The industry encounters issues in the supply chain and production, such as the timely delivery of goods to end customers and inconsistent need for services and products in the sector. Pharmaceutical and biotech companies are operating together to fight COVID-19, from supporting the production of vaccines to qualifying for supply chain concerns for drugs. Furthermore, generally used drugs like hydroxychloroquine have seen a surprising leap in the need for the control of COVID-19. Thus, driving the growth of the global market.
Regional Analysis

North America dominated the market in 2021, due to a rise in the need for biopharmaceuticals and an increase in the need for developed technologies in the cleansing of recombinant proteins made by animal cell cultures to produce valuable products of modern biotechnology.

Asia-Pacific is anticipated to notice significant growth in the global market owing to increasing R&D activities for biopharmaceuticals, an increase in acquisitions made by the key players, and a rise in government support. Furthermore, factors such as a growing professional workforce and a rising biopharmaceutical industry are also driving the growth of the global market in the region.

Leading Competitors
The prominent players in the global viral clearance market are:
Wuxi Biologics Inc.
Syngene International Limited
Sartorius Stedim Biotech
Maravai Lifesciences Holdings
Merck Kgaa
Creative Biogene
Charles River Laboratories International
Allure Medical Group
Clean Cells
Eurofins Scientific Se
Others
Segmentation Analysis
The global viral clearance market segmentation focuses on Method, Application, End User, and Region.
Segmentation on the basis of Method
Viral Removal
o Nanofiltration
o Precipitation
o Chromatography
Viral Inactivation
o Solvent Detergent Method
o Heat Pasteurization
o Low pH
o Other Viral Inactivation Methods

Segmentation on the basis of Application
Vaccine
Recombinant Proteins
Blood and Blood Products
Cellular and Gene Therapy Products
Other Applications

Segmentation on the basis of End User
Academic Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Others

Segmentation on the basis of Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com